price
PY
NASDAQ · PYXS
Pyxis Oncology, Inc. Common Stock
Healthcare · Biotechnology
$1.76
Up+$0.08 (+4.55%)
Updated Oct 21, 2026, 12:46 AM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 274.21M
- P/E ratio
- -2.84
- Dividend yield
- 0.00%
- 52-week range
- $1.03 – $5.55
- Volume
- 1.02M
- Avg. volume
- 793.75K
Price performance · PYXS
PYXS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 19, 2026
PYXS closed at $1.76 after 20 trading sessions, down 47.54% for the selected period.
- Last close
- $1.76
- Period change
- -47.54%
- Period low
- $1.68
- Period high
- $3.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | $1.69 | $1.79 | $1.675 | $1.76 | 1.02M |
| Oct 16, 2026 | $1.79 | $1.79 | $1.66 | $1.68 | 908.23K |
| Oct 15, 2026 | $1.79 | $1.84 | $1.75 | $1.80 | 545.75K |
| Oct 14, 2026 | $1.82 | $1.88 | $1.735 | $1.79 | 1.56M |
| Oct 13, 2026 | $1.99 | $1.9979 | $1.85 | $1.85 | 901.75K |
| Oct 12, 2026 | $2.03 | $2.08 | $1.99 | $2.01 | 505.67K |
| Oct 9, 2026 | $1.99 | $2.06 | $1.98 | $2.03 | 950.42K |
| Oct 8, 2026 | $2.03 | $2.03 | $1.9019 | $1.99 | 1.1M |
| Oct 7, 2026 | $2.02 | $2.086 | $2.00 | $2.01 | 957.97K |
| Oct 6, 2026 | $2.22 | $2.22 | $2.00 | $2.02 | 1.41M |
| Oct 5, 2026 | $2.12 | $2.2598 | $2.05 | $2.24 | 1.52M |
| Oct 2, 2026 | $2.21 | $2.31 | $2.10 | $2.14 | 2M |
| Oct 1, 2026 | $2.31 | $2.31 | $2.19 | $2.19 | 2.6M |
| Sep 30, 2026 | $2.375 | $2.41 | $2.12 | $2.33 | 8.15M |
| Sep 29, 2026 | $2.94 | $2.94 | $2.83 | $2.90 | 335.46K |
| Sep 28, 2026 | $2.81 | $2.91 | $2.75 | $2.90 | 368.42K |
| Sep 25, 2026 | $2.91 | $2.92 | $2.785 | $2.86 | 609.8K |
| Sep 24, 2026 | $3.22 | $3.25 | $2.86 | $2.92 | 879.4K |
| Sep 23, 2026 | $3.36 | $3.36 | $3.20 | $3.22 | 433.87K |
| Sep 22, 2026 | $3.21 | $3.405 | $3.19 | $3.355 | 480.07K |
Latest PYXS news
The latest Smart Investors Daily articles mentioning PYXS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

